annual total liabilities:
$3.53B+$199.86M(+6.01%)Summary
- As of today (May 29, 2025), EXAS annual total liabilities is $3.53 billion, with the most recent change of +$199.86 million (+6.01%) on December 31, 2024.
- During the last 3 years, EXAS annual total liabilities has risen by +$228.64 million (+6.93%).
- EXAS annual total liabilities is now at all-time high.
Performance
EXAS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$3.31B-$211.72M(-6.00%)Summary
- As of today (May 29, 2025), EXAS quarterly total liabilities is $3.31 billion, with the most recent change of -$211.72 million (-6.00%) on March 31, 2025.
- Over the past year, EXAS quarterly total liabilities has increased by +$70.46 million (+2.17%).
- EXAS quarterly total liabilities is now -6.33% below its all-time high of $3.54 billion, reached on September 30, 2024.
Performance
EXAS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EXAS Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.0% | +2.2% |
3 y3 years | +6.9% | +2.5% |
5 y5 years | +189.6% | +72.3% |
EXAS Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +10.8% | -6.3% | +4.1% |
5 y | 5-year | at high | +189.6% | -6.3% | +72.3% |
alltime | all time | at high | >+9999.0% | -6.3% | >+9999.0% |
EXAS Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $3.31B(-6.0%) |
Dec 2024 | $3.53B(+6.0%) | $3.53B(-0.3%) |
Sep 2024 | - | $3.54B(+1.6%) |
Jun 2024 | - | $3.48B(+7.3%) |
Mar 2024 | - | $3.24B(-2.5%) |
Dec 2023 | $3.33B(+4.5%) | $3.33B(+0.8%) |
Sep 2023 | - | $3.30B(+0.0%) |
Jun 2023 | - | $3.30B(+1.6%) |
Mar 2023 | - | $3.25B(+2.0%) |
Dec 2022 | $3.18B(-3.4%) | $3.18B(-0.4%) |
Sep 2022 | - | $3.20B(-0.9%) |
Jun 2022 | - | $3.23B(-0.1%) |
Mar 2022 | - | $3.23B(-2.0%) |
Dec 2021 | $3.30B(+22.6%) | $3.30B(+3.1%) |
Sep 2021 | - | $3.20B(+1.0%) |
Jun 2021 | - | $3.17B(+2.6%) |
Mar 2021 | - | $3.09B(+14.7%) |
Dec 2020 | $2.69B(+120.9%) | $2.69B(+33.3%) |
Sep 2020 | - | $2.02B(+3.1%) |
Jun 2020 | - | $1.96B(+1.7%) |
Mar 2020 | - | $1.92B(+58.0%) |
Dec 2019 | $1.22B(+44.4%) | $1.22B(+20.4%) |
Sep 2019 | - | $1.01B(-0.5%) |
Jun 2019 | - | $1.02B(+2.3%) |
Mar 2019 | - | $993.61M(+17.9%) |
Dec 2018 | $843.08M(+978.9%) | $843.08M(+6.3%) |
Sep 2018 | - | $792.85M(+7.4%) |
Jun 2018 | - | $738.26M(+29.5%) |
Mar 2018 | - | $569.90M(+629.3%) |
Dec 2017 | $78.14M(+87.2%) | $78.14M(+30.2%) |
Sep 2017 | - | $60.03M(+43.3%) |
Jun 2017 | - | $41.91M(+2.9%) |
Mar 2017 | - | $40.74M(-2.4%) |
Dec 2016 | $41.74M(+12.3%) | $41.74M(+2.1%) |
Sep 2016 | - | $40.88M(+4.4%) |
Jun 2016 | - | $39.14M(+10.4%) |
Mar 2016 | - | $35.45M(-4.6%) |
Dec 2015 | $37.17M(+55.9%) | $37.17M(+13.7%) |
Sep 2015 | - | $32.70M(+16.1%) |
Jun 2015 | - | $28.18M(+36.7%) |
Mar 2015 | - | $20.61M(-13.6%) |
Dec 2014 | $23.84M(+110.8%) | $23.84M(+21.9%) |
Sep 2014 | - | $19.56M(+51.2%) |
Jun 2014 | - | $12.94M(+4.6%) |
Mar 2014 | - | $12.37M(+9.4%) |
Dec 2013 | $11.31M(-16.4%) | $11.31M(+8.7%) |
Sep 2013 | - | $10.41M(+8.1%) |
Jun 2013 | - | $9.63M(-11.3%) |
Mar 2013 | - | $10.86M(-19.7%) |
Dec 2012 | $13.52M | $13.52M(+5.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2012 | - | $12.80M(+6.1%) |
Jun 2012 | - | $12.06M(-0.7%) |
Mar 2012 | - | $12.14M(-9.8%) |
Dec 2011 | $13.46M(-19.7%) | $13.46M(-3.2%) |
Sep 2011 | - | $13.90M(-4.9%) |
Jun 2011 | - | $14.61M(-2.3%) |
Mar 2011 | - | $14.96M(-10.8%) |
Dec 2010 | $16.76M(-14.8%) | $16.76M(-7.8%) |
Sep 2010 | - | $18.17M(-2.1%) |
Jun 2010 | - | $18.56M(-4.1%) |
Mar 2010 | - | $19.35M(-1.7%) |
Dec 2009 | $19.68M(+136.2%) | $19.68M(-5.0%) |
Sep 2009 | - | $20.72M(-5.7%) |
Jun 2009 | - | $21.97M(-5.0%) |
Mar 2009 | - | $23.12M(+177.5%) |
Dec 2008 | $8.33M(+0.3%) | $8.33M(+6.9%) |
Sep 2008 | - | $7.79M(+6.9%) |
Jun 2008 | - | $7.29M(-4.0%) |
Mar 2008 | - | $7.59M(-8.6%) |
Dec 2007 | $8.31M(-6.8%) | $8.31M(+16.5%) |
Sep 2007 | - | $7.13M(+4.2%) |
Jun 2007 | - | $6.84M(-11.5%) |
Mar 2007 | - | $7.73M(-13.3%) |
Dec 2006 | $8.91M(-32.6%) | $8.91M(-8.4%) |
Sep 2006 | - | $9.72M(-11.5%) |
Jun 2006 | - | $10.98M(-6.9%) |
Mar 2006 | - | $11.79M(-10.8%) |
Dec 2005 | $13.22M(-27.1%) | $13.22M(-6.1%) |
Sep 2005 | - | $14.08M(-7.5%) |
Jun 2005 | - | $15.22M(-5.5%) |
Mar 2005 | - | $16.10M(-11.2%) |
Dec 2004 | $18.13M(-19.3%) | $18.13M(-4.9%) |
Sep 2004 | - | $19.05M(-7.1%) |
Jun 2004 | - | $20.52M(-5.9%) |
Mar 2004 | - | $21.80M(-2.9%) |
Dec 2003 | $22.45M(+91.3%) | $22.45M(-8.7%) |
Sep 2003 | - | $24.58M(+136.8%) |
Jun 2003 | - | $10.38M(-5.6%) |
Mar 2003 | - | $11.00M(-6.3%) |
Dec 2002 | $11.74M(+184.0%) | $11.74M(-8.9%) |
Sep 2002 | - | $12.88M(-3.4%) |
Jun 2002 | - | $13.34M(+182.5%) |
Mar 2002 | - | $4.72M(+14.2%) |
Dec 2001 | $4.13M(+204.1%) | $4.13M(+41.7%) |
Sep 2001 | - | $2.92M(+61.1%) |
Jun 2001 | - | $1.81M(+27.1%) |
Mar 2001 | - | $1.42M |
Dec 2000 | $1.36M(+295.2%) | - |
Dec 1999 | $343.90K(-16.1%) | - |
Dec 1998 | $410.00K | - |
FAQ
- What is Exact Sciences annual total liabilities?
- What is the all time high annual total liabilities for Exact Sciences?
- What is Exact Sciences annual total liabilities year-on-year change?
- What is Exact Sciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Exact Sciences?
- What is Exact Sciences quarterly total liabilities year-on-year change?
What is Exact Sciences annual total liabilities?
The current annual total liabilities of EXAS is $3.53B
What is the all time high annual total liabilities for Exact Sciences?
Exact Sciences all-time high annual total liabilities is $3.53B
What is Exact Sciences annual total liabilities year-on-year change?
Over the past year, EXAS annual total liabilities has changed by +$199.86M (+6.01%)
What is Exact Sciences quarterly total liabilities?
The current quarterly total liabilities of EXAS is $3.31B
What is the all time high quarterly total liabilities for Exact Sciences?
Exact Sciences all-time high quarterly total liabilities is $3.54B
What is Exact Sciences quarterly total liabilities year-on-year change?
Over the past year, EXAS quarterly total liabilities has changed by +$70.46M (+2.17%)